undamentalytics Newsletter
Sign in

Vericel Corp cash flow statement

In fiscal 2025, Vericel Corp's operations generated $51.9m of cash; it spent $27.2m on capital projects, leaving free cash flow of $24.7m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jun 20092010Jun 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−14−15−24−30−20−25−13−20−13−0−718291835585270
Depreciation and amortisation11110122212234561213
Stock-based pay11441132371314343732363937
Capital spending001001212333882064278
Free cash flow−14−15−26−30−20−26−16−21−15−3−1015211015−62562
Free cash flow after stock pay−15−16−29−33−21−27−19−24−17−10−231−13−27−17−42−1424
Shares issued918038145001984————625147

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ADPT vs VCELVCEL vs VIRARVN vs VCELIOVA vs VCEL

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Vericel Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Vericel Corp.